Interestingly, PrPC expression was found to increase the sensitivity to doxorubicin in MDA-MB-435 breast cancer cells, unlike colorectal cancer, suggesting a tumor type-specific mechanism [71]. The gene discussed is PRNP; the disease is breast carcinoma.